drugset / Trial / NCT02863705
Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the long-term efficacy and safety of COMBIGAN® (brimonidine tartrate/timolol malate) in patients only using COMBIGAN® (brimonidine tartrate/timolol malate) and also in patients who require additional IOP lowering with LUMIGAN® (bimatoprost) 0.01%.
Timeline
- Start
- 2016-07-05
- Primary completion
- 2018-07-25
- Completion
- 2018-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.01 % | Other |
| Subject | Brimonidine | Small molecule | — | Other |
| Subject | Timolol | Other / unclassified | — | Other |